Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May 20;9(1):58.
doi: 10.1186/s13613-019-0532-9.

Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis

Ying Wang  1 , Huan Lin  2 , Bing-Wen Lin  3 , Jian-Dong Lin  4
Affiliations
Review

Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis

Ying Wang et al. Ann Intensive Care. .

Abstract

Background: Low levels of ascorbic acid (AA) have been detected in critically ill patients in which AA supplementation leads to promising outcomes. However, the ability of AA to reduce mortality in critically ill patients remains controversial. In this study, we have performed a meta-analysis to evaluate the effects of AA dose on the mortality of critically ill adults.

Methods: Electronic databases were searched for trials in which AA had been intravenously administered to critically ill patients regardless of the dose or the co-administration of antioxidant agents. The predefined primary outcome included all-cause mortality at final follow-up.

Results: The included trials enrolled a total of 1210 patients. Intravenous (IV) AA doses of 3-10 g/d reduced the mortality of critically ill patients (OR 0.25; 95% CI (0.14-0.46); p < 0.001; I2 = 0.0%), while low (< 3 g/d) and high AA doses (≥ 10 g/d) had no effect (OR 1.44; 95% CI (0.79-2.61); p = 0.234; I2 = 0.0% versus OR 1.12; 95% CI (0.62-2.03); p = 0.700; I2 = 0.0%). AA was associated with a decreased duration of vasopressor support and mechanical ventilation, but did not influence fluid requirement or urine output during the first 24 h of admission. The number of patients suffering from acute kidney injury and the length of intensive care unit or hospital stays were also unaffected by the AA.

Conclusion: Intravenous AA reduces the duration of vasopressor support and mechanical ventilation; 3-10 g AA results in lower overall mortality rates. Given the limitations of the primary literature, further studies are required to fully clarify the effectiveness of AA during the management of critically ill patients.

Keywords: Ascorbic acid; Burn; Critical illness; Sepsis; Septic shock.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing of interest nor any financial interest in any product mentioned in this paper.

Figures

Fig. 1
Fig. 1
Study flow diagram chart
Fig. 2
Fig. 2
Risk of bias summary
Fig. 3
Fig. 3
Forest plot of the effect of IV AA on mortality at the final follow-up when compared by the AA dose
Fig. 4
Fig. 4
Forest plot of the effect of IV AA on mortality at the final follow-up when compared by the characteristics of patients
Fig. 5
Fig. 5
Forest plot of the effect of IV AA on the length of ICU stay, the fluid requirement or urine output in the first 24 h of admission, and the duration of vasopressor requirement
Fig. 6
Fig. 6
Forest plot of the effect of IV AA on the duration of mechanical ventilation and the length of hospital stay
See this image and copyright information in PMC

References

    1. Goode HF, Webster NR. Free radicals and antioxidants in sepsis. Crit Care Med. 1993;21(11):1770. - PubMed
    1. Wu F, Schuster DP, Tyml K, et al. Ascorbate inhibits NADPH oxidase subunit p47phox expression in microvascular endothelial cells. Free Radic Biol Med. 2007;42(1):124–131. - PubMed
    1. Yu-Lei G, Bin L, Jian-Hua Z, et al. The parenteral vitamin c improves sepsis and sepsis-induced multiple organ dysfunction syndrome via preventing cellular immunosuppression. Mediators Inflamm. 2017;2017:1–12. - PMC - PubMed
    1. Long CL, Maull KI, Krishnan RS, et al. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res. 2003;109(2):144–148. - PubMed
    1. Schorah CJ, Downing C, Piripitsi A, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr. 1996;63(5):760–765. - PubMed

LinkOut - more resources